BioRestorative Capital Expenditures vs Begin Period Cash Flow Analysis

BRTX Stock

USD 1.48 0.02 1.33%

BioRestorative Therapies financial indicator trend analysis is way more than just evaluating BioRestorative Therapies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRestorative Therapies is a good investment. Please check the relationship between BioRestorative Therapies Capital Expenditures and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Capital Expenditures vs Begin Period Cash Flow

Capital Expenditures vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRestorative Therapies Capital Expenditures account and Begin Period Cash Flow. At this time, the significance of the direction appears to have very week relationship.

The correlation between BioRestorative Therapies' Capital Expenditures and Begin Period Cash Flow is 0.23. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of BioRestorative Therapies, assuming nothing else is changed. The correlation between historical values of BioRestorative Therapies' Capital Expenditures and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of BioRestorative Therapies are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Capital Expenditures i.e., BioRestorative Therapies' Capital Expenditures and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by BioRestorative Therapies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of BioRestorative Therapies operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from BioRestorative Therapies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.Selling General Administrative is likely to drop to about 7.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.2 M in 2024

BioRestorative Therapies fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Current Assets	Treasury Stock	Short Term Debt	Current Deferred Revenue	Non Currrent Assets Other
Total Assets		0.15	-0.65	0.96	-0.64	0.95	-0.73	0.05	-0.29	0.24	-0.7	0.26	-0.84	-0.8	0.7	-0.05	-0.39	0.97	0.72	-0.31	0.84	0.97	0.38	-0.6	-0.47	-0.63
Other Current Liab	0.15		0.22	0.04	0.09	0.25	0.16	-0.25	-0.37	0.61	0.05	0.46	0.23	-0.44	-0.25	0.46	0.05	0.19	0.41	-0.3	0.34	0.19	0.11	0.17	0.12	-0.45
Total Current Liabilities	-0.65	0.22		-0.8	0.77	-0.57	0.94	-0.28	-0.33	0.29	0.74	0.04	0.59	0.32	-0.38	0.34	0.13	-0.57	-0.46	-0.26	-0.38	-0.57	-0.22	0.91	0.53	0.25
Total Stockholder Equity	0.96	0.04	-0.8		-0.72	0.89	-0.88	0.16	-0.13	0.12	-0.81	0.19	-0.82	-0.68	0.63	-0.18	-0.4	0.91	0.7	-0.22	0.74	0.91	0.38	-0.74	-0.58	-0.51
Accounts Payable	-0.64	0.09	0.77	-0.72		-0.6	0.73	-0.23	-0.35	0.35	0.41	0.11	0.44	0.39	-0.35	0.5	-0.1	-0.58	-0.53	-0.27	-0.45	-0.58	-0.34	0.53	0.6	0.48
Other Current Assets	0.95	0.25	-0.57	0.89	-0.6		-0.64	-0.23	-0.33	0.28	-0.64	0.22	-0.77	-0.9	0.64	0.02	-0.3	0.99	0.82	-0.23	0.93	0.99	0.49	-0.56	-0.42	-0.71
Total Liab	-0.73	0.16	0.94	-0.88	0.73	-0.64		-0.33	-0.17	0.12	0.88	-0.02	0.64	0.36	-0.38	0.38	0.36	-0.64	-0.55	0.01	-0.43	-0.64	-0.3	0.85	0.67	0.19
Intangible Assets	0.05	-0.25	-0.28	0.16	-0.23	-0.23	-0.33		0.24	-0.24	-0.24	0.1	0.02	0.34	-0.14	-0.35	-0.23	-0.19	-0.16	-0.22	-0.3	-0.2	-0.1	-0.2	-0.21	0.24
Common Stock	-0.29	-0.37	-0.33	-0.13	-0.35	-0.33	-0.17	0.24		-0.64	0.12	-0.52	0.18	0.52	-0.17	-0.59	0.6	-0.33	-0.32	0.76	-0.49	-0.33	-0.22	-0.18	-0.23	0.28
Property Plant Equipment	0.24	0.61	0.29	0.12	0.35	0.28	0.12	-0.24	-0.64		-0.19	0.78	-0.11	-0.42	0.05	0.62	-0.32	0.27	0.32	-0.62	0.38	0.27	0.28	0.11	0.14	-0.29
Short Long Term Debt Total	-0.7	0.05	0.74	-0.81	0.41	-0.64	0.88	-0.24	0.12	-0.19		-0.2	0.61	0.46	-0.28	0.15	0.58	-0.63	-0.64	0.29	-0.52	-0.63	-0.45	0.83	0.5	0.13
Property Plant And Equipment Net	0.26	0.46	0.04	0.19	0.11	0.22	-0.02	0.1	-0.52	0.78	-0.2		-0.12	-0.4	0.06	0.51	-0.14	0.21	0.25	-0.38	0.37	0.21	0.18	-0.1	0.36	-0.48
Net Debt	-0.84	0.23	0.59	-0.82	0.44	-0.77	0.64	0.02	0.18	-0.11	0.61	-0.12		0.53	-0.93	0.14	0.33	-0.84	-0.32	0.15	-0.6	-0.83	-0.11	0.56	0.34	0.39
Retained Earnings	-0.8	-0.44	0.32	-0.68	0.39	-0.9	0.36	0.34	0.52	-0.42	0.46	-0.4	0.53		-0.43	-0.24	0.2	-0.86	-0.84	0.25	-0.99	-0.86	-0.56	0.41	0.07	0.83
Cash	0.7	-0.25	-0.38	0.63	-0.35	0.64	-0.38	-0.14	-0.17	0.05	-0.28	0.06	-0.93	-0.43		-0.1	-0.14	0.73	0.11	-0.04	0.48	0.73	-0.08	-0.3	-0.18	-0.41
Non Current Assets Total	-0.05	0.46	0.34	-0.18	0.5	0.02	0.38	-0.35	-0.59	0.62	0.15	0.51	0.14	-0.24	-0.1		-0.24	0.02	0.11	-0.36	0.19	0.02	0.07	0.12	0.33	-0.12
Long Term Debt	-0.39	0.05	0.13	-0.4	-0.1	-0.3	0.36	-0.23	0.6	-0.32	0.58	-0.14	0.33	0.2	-0.14	-0.24		-0.32	-0.32	0.81	-0.23	-0.32	-0.23	0.21	0.4	-0.26
Cash And Short Term Investments	0.97	0.19	-0.57	0.91	-0.58	0.99	-0.64	-0.19	-0.33	0.27	-0.63	0.21	-0.84	-0.86	0.73	0.02	-0.32		0.74	-0.24	0.89	1.0	0.4	-0.55	-0.43	-0.67
Common Stock Shares Outstanding	0.72	0.41	-0.46	0.7	-0.53	0.82	-0.55	-0.16	-0.32	0.32	-0.64	0.25	-0.32	-0.84	0.11	0.11	-0.32	0.74		-0.29	0.86	0.74	0.78	-0.52	-0.43	-0.59
Non Current Liabilities Total	-0.31	-0.3	-0.26	-0.22	-0.27	-0.23	0.01	-0.22	0.76	-0.62	0.29	-0.38	0.15	0.25	-0.04	-0.36	0.81	-0.24	-0.29		-0.25	-0.24	-0.23	-0.17	0.19	-0.05
Other Stockholder Equity	0.84	0.34	-0.38	0.74	-0.45	0.93	-0.43	-0.3	-0.49	0.38	-0.52	0.37	-0.6	-0.99	0.48	0.19	-0.23	0.89	0.86	-0.25		0.89	0.59	-0.47	-0.14	-0.81
Total Current Assets	0.97	0.19	-0.57	0.91	-0.58	0.99	-0.64	-0.2	-0.33	0.27	-0.63	0.21	-0.83	-0.86	0.73	0.02	-0.32	1.0	0.74	-0.24	0.89		0.4	-0.55	-0.42	-0.67
Treasury Stock	0.38	0.11	-0.22	0.38	-0.34	0.49	-0.3	-0.1	-0.22	0.28	-0.45	0.18	-0.11	-0.56	-0.08	0.07	-0.23	0.4	0.78	-0.23	0.59	0.4		-0.35	-0.31	-0.36
Short Term Debt	-0.6	0.17	0.91	-0.74	0.53	-0.56	0.85	-0.2	-0.18	0.11	0.83	-0.1	0.56	0.41	-0.3	0.12	0.21	-0.55	-0.52	-0.17	-0.47	-0.55	-0.35		0.32	0.24
Current Deferred Revenue	-0.47	0.12	0.53	-0.58	0.6	-0.42	0.67	-0.21	-0.23	0.14	0.5	0.36	0.34	0.07	-0.18	0.33	0.4	-0.43	-0.43	0.19	-0.14	-0.42	-0.31	0.32		-0.14
Non Currrent Assets Other	-0.63	-0.45	0.25	-0.51	0.48	-0.71	0.19	0.24	0.28	-0.29	0.13	-0.48	0.39	0.83	-0.41	-0.12	-0.26	-0.67	-0.59	-0.05	-0.81	-0.67	-0.36	0.24	-0.14

Click cells to compare fundamentals

BioRestorative Therapies Account Relationship Matchups

BioRestorative Therapies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5M	4.3M	22.5M	16.4M	12.6M	13.2M
Other Current Liab	4.5M	609.2K	15.9K	5.5M	2.3M	1.7M
Total Current Liabilities	13.7M	1.0M	363.8K	440.3K	2.6M	2.5M
Total Stockholder Equity	(12.8M)	(1.3M)	21.6M	15.8M	10.0M	10.5M
Accounts Payable	2.0M	118.9K	50.8K	170.9K	189.4K	179.9K
Other Current Assets	35.2K	105.4K	436.2K	363.1K	305.2K	320.5K
Total Liab	14.2M	5.7M	856.5K	602.6K	2.6M	2.5M
Intangible Assets	739.2K	664.3K	589.7K	803.4K	713.7K	971.2K
Common Stock	7.8K	286.2K	353.0	369.0	471.0	447.45
Property Plant Equipment	658.3K	21.9K	395.8K	502.8K	578.2K	351.7K
Short Long Term Debt Total	7.8M	4.8M	670.7K	301.6K	162.3K	154.2K
Property Plant And Equipment Net	658.3K	495.8K	395.8K	502.8K	507.5K	420.0K
Net Debt	7.8M	1.7M	(20.4M)	(1.4M)	(722.1K)	(686.0K)
Retained Earnings	(78.6M)	(89.8M)	(134.1M)	(152.6M)	(146.7M)	(139.4M)
Cash	1.7K	3.1M	21.0M	1.7M	884.4K	840.2K
Non Current Assets Total	1.4M	1.2M	985.5K	1.3M	1.2M	1.3M
Long Term Debt	194.3K	523.9K	4.3M	191.0K	219.7K	208.7K
Cash And Short Term Investments	1.7K	3.1M	21.0M	14.7M	11.1M	11.6M
Common Stock Shares Outstanding	19.5K	394.7K	1.2M	3.6M	4.2M	4.4M
Liabilities And Stockholders Equity	1.5M	4.3M	22.5M	16.4M	12.6M	13.2M
Non Current Liabilities Total	521.9K	4.6M	492.7K	162.3K	186.7K	177.3K
Other Stockholder Equity	65.8M	88.2M	155.7M	146.6M	156.7M	164.5M
Total Current Assets	68.9K	3.2M	21.5M	15.1M	11.4M	12.0M
Short Term Debt	7.2M	316.7K	297.1K	278.7K	162.3K	154.2K
Net Tangible Assets	(13.5M)	(2.0M)	21.0M	15.0M	17.3M	18.1M
Short Long Term Debt	3.5M	3.6M	7.1M	59.0K	53.1K	50.4K
Net Receivables	32K	17K	5K	16K	19.3K	22.7K
Net Invested Capital	(5.6M)	2.9M	21.8M	15.8M	10.0M	5.9M
Net Working Capital	(13.7M)	2.1M	21.1M	14.7M	8.8M	9.2M
Capital Stock	7.8K	286.2K	15.8K	15.6K	17.9K	17.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRestorative Capital Expenditures vs Begin Period Cash Flow Analysis

Capital Expenditures vs Begin Period Cash Flow

Capital Expenditures vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Capital Expenditures

Begin Period Cash Flow

BioRestorative Therapies fundamental ratios Correlations

BioRestorative Therapies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRestorative Therapies fundamental ratios Accounts

Also Currently Popular

Additional Tools for BioRestorative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Other Current Assets
Total Current Assets	+ 0.99	Other Current Assets
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.96	Total Assets

Other Stockholder Equity	- 0.99	Retained Earnings
Cash	- 0.93	Net Debt
Retained Earnings	- 0.9	Other Current Assets
Total Liab	- 0.88	Total Stockholder Equity
Total Current Assets	- 0.86	Retained Earnings
Cash And Short Term Investments	- 0.86	Retained Earnings